Australia Legal Cannabis Market Outlook, Trends and Forecast 2026–2034
- Tanvi Shinde
- 16 minutes ago
- 4 min read
The Australia Legal Cannabis Market is witnessing strong growth due to increasing acceptance of cannabis-based therapies, expanding patient access programs, rising physician awareness, and growing investments in licensed cultivation and pharmaceutical-grade cannabis production. Increasing demand for medical cannabis products, including oils, capsules, flower products, and cannabinoid-based formulations, along with advancements in cultivation, extraction, and healthcare delivery technologies, is further supporting market expansion.
According to Fortune Business Insights, the Australia Legal Cannabis Market was valued at USD 877.23 million in 2025 and is projected to grow from USD 1,021.18 million in 2026 to USD 3,443.75 million by 2034, exhibiting a CAGR of 16.41% during the forecast period.
Why is the Australia Legal Cannabis Market Growing Rapidly?
Cannabis-based products are becoming increasingly important within Australia's regulated healthcare ecosystem. Medical cannabis remains the primary growth pillar, supported by authorized prescribing pathways, expanding patient access, growing physician familiarity, and increasing availability of pharmaceutical-grade products.
Manufacturers and industry participants are investing in cultivation technology, extraction infrastructure, research partnerships, and quality-controlled production facilities to meet growing demand. Increasing interest in CBD formulations and cannabinoid-based therapies is also encouraging product diversification across oils, capsules, topical products, and other formulations.
Legal cannabis products are increasingly used in:
Medical cannabis therapies
CBD-based formulations
Pain management applications
Neurological disorder treatments
Cancer-related symptom management
Key Market Trends Shaping Industry Growth
Rising Demand for Medicinal Cannabis Therapies
The increasing demand for alternative therapeutic solutions is one of the major factors driving the Australia Legal Cannabis Market. Patients seeking treatments for chronic pain, epilepsy, neurological disorders, cancer-related symptoms, anxiety disorders, and sleep disturbances are contributing to rising demand for cannabis-based medicines. Growing physician awareness and clinical research are further supporting adoption.
For detailed market insights, visit the Australia Legal Cannabis Market Report:
Growing Adoption of Telehealth-Based Cannabis Consultations
Telehealth-driven prescriptions and digital healthcare integration are emerging as important trends in Australia's cannabis industry. Online healthcare platforms are enabling patients to access consultations and approved medicinal cannabis products more conveniently. Cannabis companies are also strengthening partnerships with healthcare providers and pharmacy networks to improve patient accessibility.
Increasing Popularity of CBD-Dominant Formulations
CBD-dominant products are gaining popularity as consumers and healthcare providers increasingly explore cannabinoid-based formulations. Manufacturers are developing oils, capsules, topical products, and low-dose cannabinoid formulations to address growing demand for diversified cannabis products.
Expansion of Pharmaceutical-Grade Cannabis Production
Australian producers are investing in licensed cultivation facilities, advanced greenhouse systems, extraction technologies, GMP-certified operations, and research capabilities. Increasing domestic production is helping reduce reliance on imports while creating opportunities for pharmaceutical-grade cannabis manufacturing and exports.
Growing Focus on Research and Product Innovation
Research institutions, biotechnology companies, pharmaceutical organizations, and cannabis producers are increasingly collaborating to evaluate cannabinoid applications and develop specialized formulations. Clinical validation, product consistency, quality assurance, and improved dosing accuracy are becoming important competitive factors within the industry.
Market Segmentation Analysis
Marijuana Holds a Significant Market Share
Based on source, the market is segmented into:
Marijuana
Hemp
The marijuana segment accounted for approximately 58% of the market share, supported primarily by the increasing use of marijuana-derived medical cannabis products. Licensed producers are investing in pharmaceutical-grade cultivation, advanced environmental controls, genetic development, and quality testing to improve product consistency.
The hemp segment accounted for nearly 42% of the market share and is gaining importance across wellness products, nutraceuticals, cosmetics, personal care products, and industrial applications. Growing interest in hemp-derived CBD products and sustainable materials is expected to support segment expansion.
CBD Emerges as the Leading Derivative
Based on derivative, the market includes:
CBD
THC
Others
The CBD segment accounted for approximately 56% of the market, making it the leading derivative category. Demand is supported by increasing interest in CBD oils, tinctures, capsules, topical products, and wellness formulations. Manufacturers are focusing on advanced extraction technologies, formulation development, and clinical research to improve product quality and market acceptance.
Medical Use Dominates the Market
Based on end-use, the market is segmented into:
Medical Use
Recreational Use
Industrial Use
The medical use segment dominates with approximately 71% market share. The segment benefits from regulatory support, increasing physician participation, growing patient acceptance, and broader access to authorized cannabis-based treatments. Medical cannabis is increasingly used for chronic pain, epilepsy, anxiety disorders, multiple sclerosis, and cancer-related symptoms.
Recreational Cannabis Remains Limited
Recreational use accounts for approximately 18% of the market, reflecting Australia's current regulatory environment and continuing policy discussions surrounding adult-use cannabis. Future changes in regulations could significantly influence demand patterns and create additional opportunities for industry participants.
Regional Insights
Australia Strengthens Its Position in Asia Pacific
Australia has developed one of the more structured and regulated cannabis industries in the Asia-Pacific region. Increasing medical cannabis acceptance, licensed cultivation, pharmaceutical manufacturing capabilities, and investments in research and extraction technologies are supporting industry development.
Growing Investment in Domestic Production
Industry participants are increasing investments in local cultivation and pharmaceutical-grade manufacturing facilities to strengthen supply-chain stability and reduce reliance on imports. Advanced greenhouse cultivation, quality assurance systems, and GMP-certified production are becoming increasingly important to market participants.
Asia Pacific Offers Long-Term Opportunities
The broader Asia-Pacific region presents significant opportunities as countries explore medical cannabis, hemp, and cannabinoid-based applications. Increasing research activity, pharmaceutical partnerships, agricultural innovation, and regulatory development could support long-term cannabis industry growth across the region.
Competitive Landscape
Leading companies and industry participants are focusing on expanding cultivation capacity, developing pharmaceutical-grade cannabis products, improving extraction technologies, strengthening healthcare partnerships, and investing in clinical research. Companies are also emphasizing quality assurance, regulatory compliance, and product innovation to strengthen their competitive positions.
Major companies and industry participants operating in the Australia Legal Cannabis Market include:
Aurora Cannabis Inc.
Canopy Growth Corporation
Little Green Pharma Ltd.
Althea Group Holdings Limited
ECS Botanics Holdings Ltd.
Recent Industry Developments
Companies continue expanding licensed cultivation and pharmaceutical-grade cannabis production facilities to meet increasing demand.
Industry participants are investing in advanced greenhouse cultivation and extraction technologies.
Cannabis companies are strengthening partnerships with healthcare providers, pharmacies, and research institutions.
Research and development activities are increasingly focused on clinical validation, product consistency, and specialized cannabinoid applications.
Request Sample Report:
Future Outlook
The future of the Australia Legal Cannabis Market appears highly promising. Rising demand for medical cannabis therapies, increasing patient access, growing physician awareness, expanding domestic cultivation, and continued innovation in cannabinoid formulations are expected to drive substantial market growth throughout the forecast period.
Explore Japan’s Market Opportunities Latest Australia Legal Cannabis Market Insights
Comments